(Q34562973)

3 August 2017

title

A critical assessment of treatment options for idiopathic pulmonary fibrosis (English)

1 reference

3 August 2017

1 reference

Nirav R Shah

1

1 reference

3 August 2017

Paul Noble

2

1 reference

3 August 2017

Robert M Jackson

3

1 reference

3 August 2017

Talmadge E King

4

1 reference

3 August 2017

Steven D Nathan

5

1 reference

3 August 2017

Maria Padilla

6

1 reference

3 August 2017

Ganesh Raghu

7

1 reference

3 August 2017

Melissa Bruce Rhodes

8

1 reference

3 August 2017

Marvin Schwarz

9

1 reference

3 August 2017

Gregory Tino

10

1 reference

3 August 2017

Robert W Dubois

11

1 reference

3 August 2017

publication date

1 October 2005

1 reference

Sarcoidosis Vasculitis and Diffuse Lung Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

22

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

167-174

1 reference

Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

The Expert Consensus Guideline Series. Treatment of depression in women.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

The treatment of idiopathic pulmonary fibrosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1550766

Response to steroid therapy in patients of idiopathic pulmonary fibrosis: a retrospective analysis

27 October 2018

1 reference

12 December 2020

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

12 December 2020

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

12 December 2020

Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

12 December 2020

Appropriateness of surgery for sciatica: reliability of guidelines from expert panels

1 reference

12 December 2020

Time will tell: predicting survival in idiopathic interstitial pneumonia

1 reference

12 December 2020

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

12 December 2020

Physician ratings of appropriate indications for six medical and surgical procedures

1 reference

12 December 2020

Identifiers

PMC publication ID

1550766

1 reference

3 August 2017

1 reference